Invention Grant
- Patent Title: Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure
-
Application No.: US15518730Application Date: 2015-10-08
-
Publication No.: US10561709B2Publication Date: 2020-02-18
- Inventor: Mingdong Zhou
- Applicant: Zensun (Shanghai) Science & Technology, Co., Ltd.
- Applicant Address: CN Shanghai
- Assignee: Zensun (Shanghai) Science & Technology, Co., Ltd.
- Current Assignee: Zensun (Shanghai) Science & Technology, Co., Ltd.
- Current Assignee Address: CN Shanghai
- Agency: Jones Day
- Priority: CN201410550212 20141017
- International Application: PCT/CN2015/091459 WO 20151008
- International Announcement: WO2016/058493 WO 20160421
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K38/18 ; C07K14/475 ; A61K9/00 ; A61K9/19 ; A61K45/06
Abstract:
Disclosed are the use of neuregulin proteins in preparing a medicine for preventing, treating or delaying preserved ejection fraction cardiac failure in mammals, and a method for using the medicine. Also provided in the present invention is a method for preventing, treating or delaying preserved ejection fraction cardiac failure in mammals, comprising using the medication containing the neuregulin proteins in a special population having the disease or being at risk of having the disease.
Public/Granted literature
Information query
IPC分类:
